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ABNORMAL CALCIUM HANDLING BY VENTRICULAR MYOCYTES OF 
HYPERTENS!VE, CALCIUM-DEFICIENT CHICK EMBRYOS 
. . s and Rocky S. Tuan. Thomas Jefferson University, 
Philadelphia, PA ’ 
Hypertension and tachycardia develop in Caa+-deficient, shell-less 
(SL) chick embryos cultured ex ovo, accompanied by elevated 
circulating catecholamines and higher o( -adrenergic sensitivity of 
cardiovascular functions. We report here that Gas+ handling is 
altered in the heart cells of SL embryos. For this study, isalated and 
cultured ventricular myooytes of SL and normal (NL) embryos were 
loaded with Fura- via transient membrane damage with glass beads. 
Compared to Fura-2/AM, bead loading yielded similar [Cas+Jr values 
and kinetic profile and did not affect cell viability and beating activity. 
The procedure should be generally applicable for Fura- loading, 
particularly for cells with low esterase activity. The Fura- loaded 
cells were washed in Ca2+-free buffer and then analyzed for kinetic 
changes in (Caz*lr as a function of [Ca2+]0 and adrenergic modifiers 
by fluorescence Imaging microscopy. At 0.5 and 1 .O mM [Cas+]o, SL 
cells showed higher jCaz+]i (R values: SL, 0.67 61 0.93’ NL, 0.50 & 
0.74, respectively; ~~0.05) and faster rate of increase in [Cap+]; 
compared to NL cells. At higher [Gas+]. (3-5 mM), there was no 
significant difference in [Caz+]i between NL and SL cells. 
Treatment of NL or SL cells with norepinephrrne (NE; 0.01-l PM) 
at 1mM [Caz+]o substantially Increased [Cas+]r. In NL cells, the NE 
effect was completely inhibited by R-blockade (lufvl propranolol), 
which was only partially effective in SL cells. On the other hand, 
#-blockade (1uM prazosin) partially inhibited (Can+lr increase by 
NE in SL cells, but not tn NL cells. The altered Gas+ handling and 
adrenergic regulation of the heart cells may contribute to the Ca2+ 
deffciency related development of impaired cardiovascular functions 
in the chick embryos. 
DUCT1013 OF THE BARLY GRDWTH RESPONSE GENE-l, 
FOS, AND PROTEIN SYBTHES IN ADULT CARDIO- 
OCYTES BY ANGIGTEWSIN II BHDGTHRLIN 
Janis Nouskas, Joachim Luyken, 
s, R. Sanders Williams, Vikas P. 
atme, Hans Vetter, Medical Policlinic, Uni- 
versity of Bonn, Federal Republic of Germany 
We assessed the pressure-independent role of 
angiotensin II (AII) and endothelin-1 (E) in the 
development of myocardial hypertrophy using iso- 
lated adult rat cardiomyocytes. 
The transcriptional factors "early growth res- 
ponse gene-lll (Egr-1) and c-fos were investi- 
gated by Northern blotting using a 2.1 kb frag- 
ment of murine Egr-1 and v-fos (1 kb) as probes. 
At IO'%, AI1 and E induced c-fos approximately 
lo and 259fold, respectively (maximum after 15 
min, return to basal levels at 60 min). There 
was a dose-response relationship with induction 
in the physiological concentration range of AI1 
and E. Egr-1 was maximally induced at 30 min by 
AII and E with a similar dose-response relation- 
ship as c-fos. The action of AII, not E, was 
potentiated 3-fold by fetal calf serum. AI1 sti- 
mulated protein synthesis (measured using cyclo- 
heximide-inhibitable 'H-Phenylalanin incorpora- 
tion) by llO+/-14% (n=6, ~~0.05, AI1 vs con- 
trol). E in;reased protein synthesis by 223+/- 
These results indicate that AI1 and 
E are able to induce probable early (growth-re- 
lated transcriptional factors) and late (protein 
synthesis) steps in the chain of events leading 
to myocardial hypertrophy and/or remodeling. 
HEMODYNAMIC AND VASCULAR CHARACTERISTICS QF DUP 
753: A SPECIFIC ANGIOTENSIN II ANTAGONIST, IN 
THE SPONTANEOUSLY H PERTENSIVE RAT (SHR). 
Robert J. Cody, Garrie J. Haas, Philip F. 
Binkley, Douglas M. Brown. The Ohio State 
University, Columbus, OH 
DUP 753, an angiotensin II antagonist, produces 
a dose dependent antihypertensive effect. The 
present study characterized the hemodynamic 
profile of IV bolus DUP 753 in the SHR, in pre- 
paration for studies of orally administered DUP 
753. IV DUP 753 as 1 or 3 mg/kg had minimal to- 
modest effect, but 10 mg/kg produced marked 
pressure reduction. In 9 anesthetized, instru- 
mented, open-chest SHR (age 1451.2 mo, wgt 4132 
13 grams) DUP753(10mg/kg) lowered mean aortic 
pressure (MAP) from 15lk18 to 112k22 
(pcO.Ol), persisting from 15 to 60 mi 
reduction was mediated by systemic arterial re- 
sistance reduction from 1.97k.43 to I.412 .43 
units (pcO.01). While heart rate and cardiac 
output(ml/min) were unchanged,peak flow (234+55 
to 283259 ml/min pc.01) and pulse pressure 
(41212 to 49f8 mmHg pc.04) increased. Charac- 
teristic aortic impedance (1075823823 to 94192 
2377 dxS/cm' pc.05) and wave reflectance index 
(1540126744 to 10790+3298 dx5/cm3 pc.05) also 
decreased. Thus, the effect of DUP753 is med- 
iated by vasodilation without adverse cardiac 
effects. These studies document reversal of an 
adverse effect of angiotensin II on the conduit 
function of the aorta, as well as favorable 
vasodilation of resistance size arteries. 
CALCIUM VOLTAGE CHANNEL ANTAGONISM PREVENTS 
ENDOTHELIN-INDUCED HYPERTENSION. 
Robert J. Cody, Garrie J. Haas, Douglas M. 
Brown. The Ohio State University, Columbus, OH 
We have previously reported that endothelin 
(ET3) administration to normal rats causes 
brief hypotension followed by sustained hyper- 
tension, mediated by concordant changes in sys- 
temic arterial resistance (SAR,mmHg/CO per kg). 
xn vitro vascular studies suggest ET3 vasocon- 
striction may be mediated by increased vascular 
smooth muscle cytosolic calcium. This hypothe- 
sis remains controversial and has not been 
fully tested in intact animals. We gave ET3 (1 
nanomole) intravenously to 6 anesthetized 
Sprague-Dawley rats (age 15f0.5 mo; weight 
525+64 grams), during hemodynamic instrumen- 
tation. Compared to baseline, and following 
the initial brief hypotensive phase, ET3 in- 
creased mean pressure (MAP,mmHg) from IlO-+ to 
143*19(pc0.01), mediated by an increase of SAR 
(1.1720.7 to 2.30+0.9;pcO.O1). At peak vasocon- 
striction, infusion of a calcium channel ant- 
agonist (nicardipine, 3.1*1.2mcg/kg/ yin), 
reversed IwfiP from 143+10 to 106213 (pCO.Ol), 
and decre.ised SAR from 2.3020.9 to 1.40f0.6 
(pcO.01). In 4 additional rats prior adminis- 
tration of 1.7 mcg/kg/min nicardipine produced 
minimal MAP reduction, but completely prevented 
subsequent ET3 hypertension. These in vivo data 
suggest that the hypertensive response to ET3 
can be reversed ~ prevented by antagonizing 
voltage channel calcium influx in vascular 
smooth muscle. 
